A detailed history of Greenhaven Associates Inc transactions in Baxter International Inc stock. As of the latest transaction made, Greenhaven Associates Inc holds 10,693,223 shares of BAX stock, worth $198 Million. This represents 4.1% of its overall portfolio holdings.

Number of Shares
10,693,223
Previous 6,288,349 70.05%
Holding current value
$198 Million
Previous $143 Million 37.94%
% of portfolio
4.1%
Previous 2.9%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 07, 2026

BUY
$17.75 - $23.86 $78.2 Million - $105 Million
4,404,874 Added 70.05%
10,693,223 $198 Million
Q3 2025

Nov 04, 2025

BUY
$21.71 - $31.23 $137 Million - $196 Million
6,288,349 New
6,288,349 $143 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $9.31B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Greenhaven Associates Inc Portfolio

Follow Greenhaven Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenhaven Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Greenhaven Associates Inc with notifications on news.